3D Global Biotech Inc. (TPEX:6808)
40.75
+0.75 (1.88%)
Jul 21, 2026, 1:51 PM CST
3D Global Biotech Revenue
In the year 2025, 3D Global Biotech had annual revenue of 206.74M TWD, down -22.19%. 3D Global Biotech had revenue of 103.89M in the half year ending December 31, 2025, with 804.58% growth.
Revenue
206.74M
Revenue Growth
-22.19%
P/S Ratio
15.27
Revenue / Employee
n/a
Employees
43
Market Cap
3.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 206.74M | -58.95M | -22.19% |
| Dec 31, 2024 | 265.69M | 245.05M | 1,187.68% |
| Dec 31, 2023 | 20.63M | 6.99M | 51.24% |
| Dec 31, 2022 | 13.64M | 2.57M | 23.19% |
| Dec 31, 2021 | 11.08M | -2.19M | -16.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.91B |
| SYN-TECH Chem. & Pharm. | 1.26B |
| Chunghwa Chemical Synthesis & Biotech | 973.15M |
| Sagittarius Life Science | 392.26M |
| BioGend Therapeutics | 229.81M |
| Intech Biopharm | 117.49M |
| Formosa Pharmaceuticals | 54.32M |
| Shine-On BioMedical | 30.00M |